Clinical Trial Update: Efficacy and Safety of Lisdexamfetamine Dimesylate in Adults With Chronic Fatigue Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the efficacy and safety of lisdexamfetamine dimesylate in adults with Chronic Fatigue Syndrome; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairments
• Fatigue Syndrome

Drugs mentioned

• LISDEXAMFETAMINE DIMESYLATE (Lisdexamfetamine dimesylate)

Snippet

Sponsor: Rochester Center for Behavioral Medicine | Conditions: Chronic Fatigue Syndrome, Cognitive Impairments | Phase 4 | Status: COMPLETED | Results posted: 2014-06-26